This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Pertussis vaccine
- DrugBank Accession Number
- DB15274
- Background
Pertussis vaccine is under investigation in clinical trial NCT01698346 (Pertussis (Tdap) Vaccination in Pregnancy).
- Type
- Biotech
- Groups
- Approved, Investigational
- Biologic Classification
- Vaccines
Other vaccines - Synonyms
- Bordetella pertussis
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAbatacept The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Abatacept. Adalimumab The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Adalimumab. Aldesleukin The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Aldesleukin. Alefacept The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Alefacept. Alemtuzumab The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Alemtuzumab. Altretamine The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Altretamine. Amsacrine The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Amsacrine. Anakinra The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Anakinra. Anifrolumab The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Anifrolumab. Antilymphocyte immunoglobulin (horse) The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Antilymphocyte immunoglobulin (horse). 
Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice.Learn more - Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Pertussis Vaccine 4 Protect Unit Suspension 15000 m / mL Subcutaneous Aventis Pasteur Limited 1921-12-31 2001-07-19 Canada 
- Mixture Products
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 2QNL82089R
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
- 1608803
- Wikipedia
- Pertussis_vaccine
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Prevention Apnea / Apnoea neonatal / Infants, Premature 1 4 Completed Prevention Diphtheria Immunisation / Pertussis Immunisation / Poliomyelitis Vaccine / Tetanus Immunisation 1 4 Completed Prevention Diphtheria / Pertussis / Tetanus 1 4 Completed Prevention Diphtheria / Pertussis / Tetanus / Whooping Cough 2 4 Completed Prevention Febrile Convulsions / Fever / Fever After Vaccination 1 4 Completed Prevention Healthy Subjects (HS) 1 4 Completed Prevention Influenza, Human 1 4 Completed Prevention Meningococcal Meningitis 1 4 Completed Prevention Pertussis / Pregnancy 1 4 Completed Prevention Pregnancy 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Intramuscular Liquid Intramuscular Injection, suspension Parenteral Injection, powder, for suspension Intramuscular Suspension Intramuscular Injection Intramuscular Suspension Subcutaneous 15000 m / mL Injection, suspension Intramuscular Injection, suspension - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at May 20, 2019 15:06 / Updated at January 24, 2021 06:04